scispace - formally typeset
K

Krikor Dikranian

Researcher at Washington University in St. Louis

Publications -  45
Citations -  11508

Krikor Dikranian is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Neurodegeneration & Glutamate receptor. The author has an hindex of 31, co-authored 45 publications receiving 10687 citations.

Papers
More filters
Journal ArticleDOI

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

TL;DR: Blockade of N-methyl-D-aspartate (NMDA) glutamate receptors for only a few hours during late fetal or early neonatal life triggered widespread apoptotic neurodegeneration in the developing rat brain, suggesting that the excitatory neurotransmitter glutamate, acting at NMDA receptors, controls neuronal survival.
Journal ArticleDOI

Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits

TL;DR: A combination of drugs commonly used in pediatric anesthesia in doses sufficient to maintain a surgical plane of anesthesia is administered to 7-d-old infant rats, and it is observed that this causes widespread apoptotic neurodegeneration in the developing brain, deficits in hippocampal synaptic function, and persistent memory/learning impairments.
Journal ArticleDOI

Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome.

TL;DR: It is reported that ethanol, acting by a dual mechanism [blockade of N-methyl-D-aspartate (NMDA) glutamate receptors and excessive activation of GABA(A) receptors], triggers widespread apoptotic neurodegeneration in the developing rat forebrain.
Journal ArticleDOI

Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

TL;DR: It is revealed that phenytoin, phenobarbital, diazepam, clonazepam, vigabatrin, and valproate cause apoptotic neurodegeneration in the developing rat brain at plasma concentrations relevant for seizure control in humans.
Journal ArticleDOI

Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

TL;DR: It is shown that N2O, at anesthetically-relevant concentrations, inhibits both ionic currents and excitotoxic neurodegeneration mediated through NMDA receptors and, like other NMDA antagonists, produces neurotoxic side effects which can be prevented by drugs that enhance CABAergic inhibition.